DHA 2020.1 sbir direct to phase II medical r & d contract for proposal #H2D-0023, titled: "deployable wound care products to decrease preventable death outcomes by mitigating infection on…
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH20C0112
- Awardee
-
Kericure Inc. UEI U7ZGJKJZXRC4
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $2,199,745
Award facts
- Opportunity
-
- HQ003420R1DSB Solicitation number
- Contract value 100% obligated
- $2,199,745.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- AN91 R&D- Medical: Other (Basic Research)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 27 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Zephyrhills, FL 33544, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $0 | |
| Supplemental Agreement for work within scope | $1,099,759 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,099,986 |
About this award
The Department of the Army Medical Command awarded Kericure Inc.'s Kericure Medical Division a $2.2 million firm fixed price contract under the Small Business Innovation Research Program Phase II solicitation for deployable wound care products. The contract aims to decrease preventable death outcomes by mitigating infection on the battlefield and through long-term care. As a Phase II SBIR award from the Army, the contract builds upon prior research and development efforts to further mature technology for delivery. Performance will take place in Zephyrhills, Florida over a three-year period concluding in October 2023. The award is set aside for total small businesses.
Description
DHA 2020.1 sbir direct to phase II medical r & d contract for proposal #H2D-0023, titled: "deployable wound care products to decrease preventable death outcomes by mitigating infection on battlefield and through long term care"
Quick answers
Who was awarded contract W81XWH20C0112?
W81XWH20C0112 was awarded to Kericure Inc. by Medical Command (Department of the Army) on September 28, 2020.
How much is contract W81XWH20C0112 worth?
The government has obligated $2,199,745 on W81XWH20C0112.
Was contract W81XWH20C0112 competed?
The extent of competition for W81XWH20C0112 was full and open competition after exclusion of sources. The government received 27 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award